Synapse · 2005 · 20 citations · 19 references
Life SciencesNeurosciencePharmacologyCell SignalingNeurochemistryNeuropharmacologyCholinergic PharmacologyNeuromuscular JunctionNeurotransmissionNeurotransmitter ReceptorsSynaptic TransmissionAdenosine Receptor ModulationAdenosine Receptor SignalingAdenosine-mediated RegulationAxon TerminalsInhibitory TransmissionReceptor Subtype Specificity
Extracellular adenosine is present at the mammalian neuromuscular junction (NMJ) by virtue of its release from activated nerve terminals and muscle fibers, and as a metabolite of adenosine tri-phosphate, which is coreleased with acetylcholine. Two activities for adenosine have been described: an inhibitory effect presumed to be modulated by the A1 receptor subtype, and a facilitatory effect mediated by the A2A receptor subtype. To date, only pharmacological evidence is available for these actions. We have used an antibody against the A2A receptor subtype, and demonstrated that A2A receptors are present on presynaptic motor nerve terminals at NMJs but not on associated glial or muscle cells, in the mouse. These results therefore provide additional evidence that there are multiple adenosine receptors present at the NMJ, and that stimulation of quantal and nonquantal release of acetylcholine (ACh) could be mediated by A2A receptors.
19
Receptors for Purines and Pyrimidines
Geoffrey Burnstock, Alexei Verkhratsky · 2012 · 4K citations
Medicine, Biochemistry, Pharmacology +10